Weijing Sun, MD, FACP
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach (NCT02943603) | Weijing Sun, MD, FACP | 2017-01-01 |
| Phase II Study of Irinotecan and Panitumumab (NCT00836277) | Weijing Sun, MD, FACP | 2009-05-01 |
Track Weijing Sun, MD, FACP automatically
Every clearance here is in the API, with alerts when new ones post.